middle.news
Telix Surges with US$206M Q3 Revenue and Boosted FY 2025 Outlook
6:01pm on Tuesday 14th of October, 2025 AEDT
•
Healthcare
Read Story
Telix Surges with US$206M Q3 Revenue and Boosted FY 2025 Outlook
6:01pm on Tuesday 14th of October, 2025 AEDT
Key Points
Q3 2025 revenue hits US$206 million, up 53% year-over-year
FY 2025 revenue guidance increased to US$800–820 million
Gozellix gains full CMS reimbursement in the US from October 2025
Illuccix approved in 19 European markets with ongoing commercial launches
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TLX
OPEN ARTICLE